v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Collaboration revenue $ 0 $ 28,826
Total revenue 0 28,826
Operating expenses:    
Research and development expense 1,423 19,767
General and administrative expense 12,653 10,890
Loss from sale of property and equipment 920 0
Total operating expenses 14,996 30,657
Operating loss (14,996) (1,831)
Other (expense) income, net:    
Changes in fair value of investment in convertible notes receivable (2,000) 0
Dividend income 52 78
Interest income 32 15
Interest expense 0 (595)
Other expense, net (2) (40)
Total other expense, net (1,918) (542)
Net loss before provision for income taxes (16,914) (2,373)
Provision for income taxes 0 209
Net loss $ (16,914) $ (2,582)
Basic loss per common share (in USD per share) $ (2.11) $ (0.56)
Diluted loss per common share (in USD per share) $ (2.11) $ (0.56)
Weighted-average basic common shares outstanding (in shares) 8,013,840 4,619,471
Weighted-average diluted common shares outstanding (in shares) 8,013,840 4,619,471